Gaurav Chandra
Director/Board Member en ENZOLYTICS, INC. .
Perfil
Gaurav Chandra is currently the Chief Executive Officer at Biogenysis, Inc., the Director at Enzolytics, Inc. starting in 2024, and the Chief Operating Officer at Bioclonetics Immunotherapeutics, Inc. In terms of education, Dr. Chandra holds a doctorate degree from Albert Einstein College of Medicine, Inc., an undergraduate degree from Kasturba Medical College, and an MBA from the University of Colorado Denver.
Cargos activos de Gaurav Chandra
| Empresas | Cargo | Inicio |
|---|---|---|
| ENZOLYTICS, INC. | Director/Board Member | - |
Bioclonetics Immunotherapeutics, Inc.
 Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Chief Operating Officer | - |
Biogenysis, Inc.
 Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Chief Executive Officer | - |
Formación de Gaurav Chandra.
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| Kasturba Medical College | Undergraduate Degree |
| University of Colorado Denver | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENZOLYTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Health Technology |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Commercial Services |
- Bolsa de valores
- Insiders
- Gaurav Chandra
